Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study) (LDR)
Sponsor: University Hospital, Basel, Switzerland
A EARLY_PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by University Hospital, Basel, Switzerland and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2019 — Jan 2021 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jun 2019 — Aug 2019 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2019 — Jun 2019 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2018 — Jan 2019 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Dec 2017 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .